ENTITY

Reprocell Inc (4978 JP)

Analysis

Health Care • Japan

ReproCell Incorporated develops iPS (Induced Pluripotent Stem Cell) business and clinical examination for organ transplantation based on human iPS and ES (Embryonic Stem Cell) technology.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00